Correspondence to Dr Sarah Kelly; [email protected]
STRENGTHS AND LIMITATIONS OF THIS STUDY
The review collates influences on fetal safety from electronic fetal heart rate monitoring using cardiotocography from a comprehensive body of literature, including journal articles and reports from clinical and professional organisations.
The findings have been organised into a clear explanatory framework using an existing evidence-based patient safety framework.
Findings may be less relevant to lower- and middle-income countries as studies from these countries were excluded.
Introduction
Intrapartum electronic fetal monitoring using cardiotocography (EFM-CTG) is the recommended method for monitoring the fetal heart rate during labour for high-risk births in England,1 2 and in many other countries.3–6 However, suboptimal monitoring, detection and response to fetal deterioration using intrapartum EFM-CTG has remained a stubborn challenge, implicated in a large share of obstetric malpractice claims7–13 and reports of maternity service failures.14–17 Despite the relevance to safety of systems issues as diverse as work system design, availability of senior support, equipment and professional boundaries,11 18–20 efforts to address EFM-CTG problems have largely focused on training to improve individual clinical behaviour and competencies, such as improving clinicians’ EFM-CTG interpretation skills.21–23 More recently there has also been an emphasis on consideration of clinical context and triggers for escalation, but the evidence that training on its own can deliver improvement is weak.7 23 24 Current evidence also suggests that electronic decision support for fetal monitoring does not improve clinical outcomes.25
It is likely that a systems approach to fetal safety would offer valuable targets for improvement in the practice of EFM-CTG. Such an approach recognises the need to understand the effects and interactions of crucial influences, such as work system design, tasks, equipment, workspace, teamwork, culture and organisation.26 27 A key insight of systems approaches is that ‘active failures’—unsafe acts by people in direct contact with the patient or system—tend to have a causal history at multiple levels of the system, including the ‘latent conditions’ that translate into error-providing conditions or system weaknesses.28 To fully understand how safety incidents occur requires an understanding of the complex interactions between the elements of the system, at different levels, while recognising the role of internal and external factors.29
The evidence on what is known about the influences on the safety of electronic fetal monitoring practices has neither been systematically collated nor organised. Accordingly, we aimed to identify the full range of influences on the safety of EFM-CTG practices through a scoping review of the available literature, structured using an evidence-based framework for classifying contributory factors to patient safety incidents.30
Methods
Review questions and objectives
Our specific review question was: what are the influences on fetal safety in relation to intrapartum EFM-CTG in hospital-based maternity care settings?
Given the broad scope of our review, a scoping review approach was used because of its value for exploring concepts and mapping the nature and type of a wide range of evidence.31 32
Conduct and reporting
Methods for the conduct and reporting of the scoping review followed the guidelines of the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews statement31 (online supplemental appendix S3). The protocol is publicly available (https://doi.org/10.17863/CAM.51072).
Information sources and search strategy
We searched the following databases: MEDLINE, Embase, CINAHL, Web of Science, Scopus, British Nursing Index and Cochrane Library from 1 January 2001 to 25 August 2024. Full search strategies, developed with an experienced medical librarian and clinical professionals are shown in online supplemental appendix S1.
The search strategy combined keywords and MeSH terms (1) related to safety concerns in medical and maternity care and to good or poor practice, fetal outcomes and other issues related to maternity care, and (2) related to the use of EFM-CTG in labour. Additional targeted searches, hand-searching, and forward and backward citation searching were also conducted as appropriate using a flexible, iterative approach consistent with scoping review methodology to identify any further potentially relevant studies.33 34
We also searched for grey literature, including through websites relating to obstetrics, midwifery and patient safety to identify key reports and investigations (online supplemental appendix S2), and conducted searches of OpenGrey and Google Scholar using the main search terms and concepts as the database searches.
Eligibility criteria
The inclusion/exclusion criteria were developed through initial exploratory searches, piloting of title and abstract screening, an iterative learning process and research team discussion about areas of uncertainty. Such iterative development has been shown to be necessary for complex scoping reviews covering a broad range of literature.33–35
Studies were eligible for inclusion if they reported potential influences on the clinical practice of intrapartum EFM-CTG in hospital-based intrapartum maternity care settings. We took a broad perspective on such influences, including, for example, team roles, wider organisational, environmental and systems influences, maternal and fetal factors. We aimed to report all potential influences reported in the literature, even if these were sometimes conflicting.
As the scope of the review was broad, we included primary studies and secondary analyses that had the potential to inform our research question, if they were published in English from 2001 onwards, including conference abstracts. We also included reviews of all types (a change from protocol), first because some provided useful findings and second to be consistent with the structure of the many national and international reports in this area that used an overview of a range of evidence. Findings before 2001 were deemed less likely to be relevant to current practice as UK and US guidelines on EFM-CTG practice were introduced after this date.36 37 Studies that focused on intermittent monitoring (intermittent auscultation (IA)) were included if they reported factors that influenced the initiation or performance of EFM-CTG.
Although we aimed to identify potential influences on fetal safety relating to EFM-CTG practices, we did not seek to assess the effectiveness of interventions to address these factors. We therefore, for example, included studies examining training as an influence, but excluded studies examining the effectiveness of training23 and evaluations of technological modifications to traditional EFM-CTG monitoring and analysis (eg, analysis of EFM-CTG traces augmented with artificial intelligence). We also made no assumptions about the outcomes of different types of fetal monitoring, for example, EFM-CTG or IA. Studies from lower- or middle-income countries (LMICs) (as defined by the World Bank38 were excluded owing to their very different contexts.
Selection of evidence
Titles and abstracts were screened independently by two reviewers to identify any studies potentially relevant for inclusion. Disagreements about inclusion were resolved by a third experienced reviewer and/or discussion within the review team.
Studies were retained for full-text checking if it was unclear from the title/abstract if information about influences on safety in relation to EFM-CTG was reported—for example, studies reporting on perinatal mortality audits that did not mention EFM or CTG in the title or abstract. For some topics, many studies reported similar findings; for example, there were several studies reporting interobserver or intraobserver variability of EFM-CTG trace interpretation or confusion between maternal or fetal heartbeat. As our aim was to scope the literature, rather than include an exhaustive set of studies, we chose the most clearly relevant and recent studies for full-text evaluation.
Full-text screening, data extraction and synthesis
To organise the evidence relating to potential influences on fetal safety, we were guided by a best-fit framework synthesis approach39 40 structured around the Yorkshire Contributory Factors framework (the ‘YCF framework’)30 (figure 1), an evidence-based conceptual framework of 19 domains that may contribute to patient safety incidents in hospitals.30
Figure 1. Yorkshire Contributory Factors framework (reproduced from Lawton R, McEachan RRC, Giles SJ, et al. Development of an evidence-based framework of factors contributing to patient safety incidents in hospital settings: a systematic review. BMJ Quality and Safety 2012; 21(5):369-80, with permission from BMJ Publishing Group Ltd, 2024)
The YCF framework is based on synthesis of 95 reports of 83 studies conducted in multiple healthcare settings. The 19 domains range from the situational (eg, individual or team factors) to the external, such as national policies. A particularly welcome feature of the framework is that it seeks to avoid excessive focus on proximal causes of incidents (active failures) and instead broadens to a more systems-based approach that considers how working conditions and latent factors may have impacts. This kind of framework is likely to be of considerable value in helping to characterise the full range of influences on intrapartum EFM-CTG safety in maternity units.
Full-texts were screened by two reviewers in a sequential process concurrently with the data extraction. Those full texts that had no relevant data for extraction were excluded. We created a coding framework based on the 19 domains of the YCF framework. One experienced reviewer imported the studies into NVivo software and extracted and coded relevant findings directly into the framework domains. Some findings fitted into more than one domain, so multiple coding was used as required. To ensure all relevant findings were identified, data were also extracted independently by another reviewer into an Excel spreadsheet and cross-checked against the extracted and coded data in NVivo. Any additional findings identified from this cross-check were also coded into the YCF framework domains. Disagreements were resolved by discussion within the review team. Regular project team meetings facilitated close scrutiny of coding decisions and the mapping to the framework. Within each domain, where several studies reported similar findings, results and studies were further grouped together and organised thematically.
We focused on extracting relevant findings that related to incidents or practice that specifically related to EFM-CTG, with the YCF framework used as a structured framework to organise the findings. Although the YCF framework is based specifically on contributory factors to patient safety incidents, we included a broader range of influences in this review, including issues that could influence the conduct, interpretation or response to EFM-CTG, not solely those based on patient safety incidents. For example, interobserver and intraobserver variability in trace interpretation are influences on the safety of EFM-CTG, even if they do not directly contribute to a particular incident. A small number of studies discussed findings in relation to fetal safety in general that were indirectly relevant to EFM-CTG (eg, need for examination of root causes in the incident investigation), so were included but marked as indirect influences.
A formal quality assessment was not conducted; it is not usually included in scoping reviews.31
Patient and public involvement
None.
Results
We included 142 journal articles and 14 major reports in the review (flowchart, figure 2). Full details and references of included studies are in online supplemental table S1. The majority of included studies were from the US (n=42) and the UK (n=31), while 18 were from Australia, 8 each from Norway and Canada, 7 from the Netherlands, 5 from Italy, 4 from France, 3 from Sweden and 2 from Belgium, with the remainder from other countries (full details in online supplemental table S1). The studies and reports were diverse, including journal articles examining litigation or malpractice, clinical audits and reviews of adverse events, qualitative studies, reviews, surveys, observational studies, case studies, secondary analyses of trial data and key reports from obstetric and midwifery organisations and investigations.
Figure 2. PRISMA flow diagram. EFM, electronic fetal monitoring; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Findings on numerous potential influences on safety in relation to EFM-CTG reported in the literature were extracted and mapped to the YCF framework. Where information was extracted from the papers, we used the terminology employed by the authors themselves as the basis of findings reported in online supplemental table S1. What we could extract from the studies depended on the potential influences on fetal safety and the level of detail as reported by the study authors. The information presented in papers was sometimes limited, with little detail, for example, on what type of fetal monitoring (eg, IA or EFM-CTG) was under discussion. Unless the context suggested otherwise, we considered EFM-CTG to be included in the terms used to describe fetal monitoring. Views on best practice relating to CTG varied across studies. Similarly, most studies reported from a clinical or professional viewpoint, with little reporting on whether the views of those giving birth had been taken into account in the decision. To stay faithful to the underlying findings, we extracted all potential influences reported, even if these were sometimes conflicting.
We found that, in general, it was possible to categorise study findings about influences on EFM-CTG safety using the 19 domains of the YCF framework (figure 1).
Due to space restrictions, only key findings are summarised in box 1. To fully demonstrate the huge range and diversity of system influences on fetal safety, online supplemental table S2 shows the full scope of findings mapped to the domains of the Yorkshire contributory factors framework.
Box 1Examples of influences on active failures in the practice of electronic fetal heart rate monitoring using cardiotocography (EFM-CTG), based on the Yorkshire Contributory Factors framework (for the full range of influences identified see online supplemental table S2)
Domain 1: situational factors
Team factors
Absence of interdisciplinary teamwork and under-appreciation of all roles in the team. Existence of hierarchies of power and fear of speaking up in situations of disagreement with colleagues.
Individual staff factors
Variations in beliefs about the accuracy and safety of EFM-CTG. Variations in experience and confidence. Fatigue, stress, cognitive overload and biases, attention and perception deficits and intentional violations.
Task characteristics
Complexity of EFM-CTG interpretation, with high inter and intraobserver error.
Patient factors
Potential factors influencing EFM-CTG including maternal obesity, fetal gestational age and fetal growth restriction.
Domain 2: local working conditions
Workload and staffing issues
High staff workload. Staff shortages and inability to recruit appropriate staff. Reliance on locum midwives or unskilled workforce (eg, students). EFM-CTG used to monitor low-risk women to cope with high workload. Staff not empowered to escalate when workload becomes difficult to manage. Inappropriate deployment, for example, spending time on tasks that could be done by administrative or support staff.
Leadership, supervision and roles
Lack of strong institutional, midwifery and obstetric leadership. Tensions between midwifery and obstetrics in boundaries of work in relation to EFM-CTG. Senior staff not attending escalation requests. Lack of, poor quality or non-adherence to local guidelines for EFM-CTG including response and escalation procedures.
Equipment and supplies
Poor availability and maintenance of equipment, including lack of knowledge and defined roles in maintenance. Technical difficulties in obtaining adequate EFM-CTG traces. EFM-CTG systems need to be interoperable with other technology and information technology systems.
Domain 3: organisational factors
Physical environment
Cluttered spaces or designs impeding visibility or access to critical information (not CTG specific: evidence from wider maternity safety concerns). Frequency of EFM-CTG checking impacted by maternity care setting (eg, single room vs maternity ward). Non-actionable alarms causing sensory overload.
Support from central functions
Lack of organisational resources and systems to support escalation and intervention.
Scheduling and bed management
Lack of beds in labour ward for women whose clinical situation worsens, especially for induction of labour.
Staff training and education
Lack of regular, standardised and up-to-date training and opportunities to complete such training. Lack of evidence on optimal mode and content of training.
Domain 4: external factors
Design of equipment and supplies
Difficult to maintain monitoring when moving around or between wards. Lack of standardisation of alerts and alarms. Confusion between maternal and fetal heart rate.
National policies
Multiple, inconsistent and unclear guidelines for EFM-CTG interpretation and response. Administrative overload due to a large number of national/governance initiatives.
Domain 5: communication and culture
Safety culture
Lack of clarity on what constitutes an incident worth reporting; lack of investigation of causes of incidents; fear of the consequences of reporting incidents. Fear of litigation influencing use of EFM-CTG even in low-risk women, and defensive practice.
Verbal and written communication
Multiple problems of communication including inadequate documentation of EFM-CTG, lack of consistent terminology to describe and communicate fetal heart rate (FHR) patterns and inadequate information at handovers.
‘Active failures’ are defined in the YCF framework as ‘any failure in performance or behaviour (eg, error, mistake, violation) of the person at the “sharp-end” (the health professional)’.30 Many studies and reports in our review reported active failures such as ‘errors in CTG interpretation’ or ‘no response to abnormal CTG trace’, but little accompanying investigation or analysis of why it happened, and minimal accompanying information (full detail of ‘active failures’ is reported in online supplemental table S2). We mapped potential influences on ‘active failures’ to the other domains of the YCF framework (online supplemental table S2). Selected examples are shown in box 1 and include situational factors, local working conditions, organisational factors, external factors, and communication and culture.
Many studies reported structural issues such as high staff workload and staff shortages as influences on suboptimal EFM-CTG performance (box 1, online supplemental table S2), for example, by contributing to cognitive overload, attention strains and perception deficits that result in abnormal EFM-CTG traces being missed or escalation delayed. Equipment-related issues were also repeatedly identified, including availability and maintenance, the potential for machines to confuse the maternal and fetal heart rate, difficulties in obtaining adequate tracings and chart speed variations. Several studies reported the potential for maternal or fetal characteristics to affect the EFM-CTG signal or trace or to make it more difficult to obtain a good trace.
Under the ‘external policy context’ domain, influencing factors identified in the literature include the volume and diversity of clinical guidelines and recommendations from different national and international organisations in relation to EFM-CTG (eg, Royal College of Obstetricians and Gynecologists (RCOG), American College of Obstetricians and Gynecologists (ACOG), International Federation of Gynaecology and Obstetrics (FIGO), National Institute for Health and Care Excellence (NICE)). These directions are not always consistent and may conflict or fail to cohere. Lack of local or departmental guidelines, poor quality of local guidelines and non-compliance with national guidelines, including procedures for response and escalation were all identified.
The studies we included emphasised the importance of EFM-CTG interpretation training, but also reported that lack of standardisation of guidelines and/or training may lead to different procedures and systems in different units which may contribute to inconsistencies when staff move between different units. They highlighted the importance of experience for effective EFM-CTG interpretation, suggesting that on-the-job training and supervision is also required. Studies also identified a need for training in EFM-CTG practices beyond interpretation, for example, in relation to escalation procedures and wider systems and human factors (box 1).
We found two areas of findings that were not fully accounted for in the YCF framework. First, studies reported fear of litigation as an influence because of its tendency to encourage defensive practice and the ubiquitous use of EFM-CTG. We placed this finding in the ‘external policy context’ domain after discussion within the review team. Second, we identified that findings mapped to the ‘active failures’ domain could occur at different stages and time points as labour progressed (eg, at the initial stage of decision-making about the method of monitoring through to response to deterioration), as well as transfer, induction, epidural or preparation to expedite the birth The YCF framework may not sufficiently account for these kinds of changes over time.
Discussion
Main findings
This scoping review offers a comprehensive overview of influences on practice in relation to intrapartum electronic fetal monitoring, mapped against a major patient safety framework. The full range of potential system influences on fetal safety is extensive and diverse (online supplemental table S2). The studies we reviewed suggest that structural issues—such as inadequate staffing levels, high staff workload, equipment defects and variable practice guidance—require attention, but process issues—including tasks and roles, situational factors, communication and culture—also likely to be consequential. These findings suggest that detection and response to fetal deterioration using EFM-CTG occurs in a complex adaptive system in which features of work systems (eg, staffing, resourcing, equipment, training, guidance, cultural norms, professional hierarchies and relations) have the potential to affect behaviours, decisions and actions, and ultimately outcomes. This analysis is helpful in shifting the focus from proximal causes of incidents (active failures) to a broader and more helpful focus on the influences of latent factors and working conditions on EFM-CTG safety. It adds to the evidence that a whole-systems approach41 is important to understanding and addressing the effects and interactions of real-world contexts such as teamwork, tasks, equipment, workspace, culture and organisation on clinical performance,26 27 and provides more clarity about actionable issues that could be targeted by improvement efforts.
Many of the issues identified by our review have been raised previously,2 13 but the evidence regarding the specific influences on EFM-CTG have neither previously been systematically collated nor organised into a clear explanatory framework. Our findings provide a framework identifying the factors that could be addressed by whole systems approaches.42 The findings could also support future incident investigations into safety issues in EFM-CTG by providing a structured approach to investigation and support,29 and avoiding excess focus on ‘human error’.7 8 43
Interpretation (in light of other evidence)
Reducing avoidable harm linked to sub-optimal practice of EFM-CTG requires a sound understanding of the range of influences on practice. This review has categorised influences into the separate domains of the YCF framework, but it is apparent that these are inter-related and recursive: they are multifactorial, interconnected, and contingent, and dynamically interdependent. Addressing these challenges requires a shift to the system as the unit of analysis.29 It should be acknowledged that EFM-CTG cannot be considered in isolation. In complex systems, understanding the behaviour of individual components is not enough; performance emerges from dynamic interactions across the entire system.44
Our review confirms that detecting and responding to fetal deterioration using EFM-CTG requires structures, systems, culture and processes that support a reliable and safe care pathway that is personalised and responsive to individuals. Only in this way will we be able to grasp how individual decisions and actions are made, and how they are subject to multiple and sometimes contradicting pressures, standards and influences.44 In these conditions, dynamic trade-offs are commonplace and inevitable.45 Understanding these trade-offs, and how to influence them, requires targeting the range of systems in which EFM-CTG is nested: the team, the maternity unit, and the hospital, each with its individual and collective working conditions, workload and culture; the healthcare system, with its policies and incentives; a scientific and professional environment, with evolving recommendations and debates; and the wider society, with often diverse expectations.46
This study was conducted concurrently with a recently published qualitative study conducted across three maternity units in the UK,47 examining the everyday practice of CTG monitoring and the work systems within which it takes place. This review reinforces and expands many of the findings of the qualitative study, highlighting the importance of a socio-technical approach to understanding influences on safety and the need for systems principles to address issues in EFM-CTG practice. The use of systems principles would help to minimise the use of interventions unlikely to be effective, and to design and implement those more likely to work.29 The science of human factors and ergonomics offers methods, frameworks and models to support this endeavour.48 Improvement will require high-quality human-factors-guided design that is attentive to how people, technology, procedures, and local and wider environment interact together to generate outcomes.49 Work system design should therefore be a priority and is likely to require: understanding people’s needs and capabilities; considering tools, equipment and environments; describing explicitly the tasks that people will need to do and assigning them to roles; developing clear, consensually agreed protocols and associated instructions; and a system for continuous learning and improvement.
Accordingly, our review suggests that training is indeed essential, but individual training in EFM-CTG interpretation alone is not enough.23 Current recommendations that EFM-CTG training should promote team-working and consider non-clinical skills such as clinical risk factors, situational awareness and human factors are likely to benefit from improved specificity to ensure relevance and usability.50 51 Further, our review identified some ‘active failures’ associated with EFM-CTG relate to changing circumstances as labour progresses, and more focus may be needed on ensuring that care pathways are sufficiently flexible to allow for women’s changing needs and input from multiple professionals.52
Strengths and limitations
A scoping review attempts to capture the breadth of the research rather than aim for exhaustivity. As such, we did not obtain full papers for every study identifying a theme but instead chose the most recent or most relevant. The review was limited to 2001 onwards and to studies from higher-income countries, so the findings may be less relevant to LMICs. Although the review highlights that delays in adequate responses concerning EFM-CTG are an ‘active failure’ influence on fetal safety, full reasons for the lack of a timely response were seldom investigated or reported in the studies.
A strength of this review is the comprehensive range of literature examined, and the mapping to an existing evidence-based framework in patient safety. Although some of the findings have previously been reported in the broader maternity and patient safety literature,14 15 50 this review collates and presents together, the range of issues across a very broad range of literature. The YCF framework provided a useful structure to organise the large amount of evidence identified. A particularly valuable feature of the framework is that it seeks to avoid excessive focus on proximal causes of incidents (active failures), instead offering a more systems-based approach that considers working conditions and latent factors, embedded behind the apparent ‘active failures’, to understand the root causes of safety errors. However, we recognise that the YCF framework describes contributory factors for identified patient-safety incidents and that the potential ‘influences’ identified in this review may not be identical.
Conclusions
Influences on patient safety in EFM-CTG are multifactorial. Given the scale of harm and litigation claims associated with intrapartum fetal monitoring, improvement strategies should consider the range of influences identified by this review. Tackling the full range of potential contributory factors will require fresh thinking about the problems to be solved, the targets for intervention and the design of solutions.
We thank the following for their support of the review through involvement in title/abstract screening and additional methodological development work around screening decisions embedded in this review using the Thiscovery platform (https://www.thiscovery.org):- Jasmine Bawa, Bhurint Siripanthong, Aiman Aslam, Holly Hellawell, Fazal Shah, Sofia Weiss, Maria Ionescu, Maaz Khan. We also thank RAND Europe for their contribution to title/abstract screening.
Data availability statement
All data relevant to the study are included in the article or uploaded as supplementary information.
Ethics statements
Patient consent for publication
Not applicable.
Ethics approval
Not applicable.
X @ilk21
Contributors SK, GL, JB, MD-W, TJD and CW led on the planning of the review and methodology. The search terms were defined by GL, JB, IK, SK, TJD and CW. IK designed and conducted the searches and exported the results. Title and abstract screening was conducted by SK, GL, EL, HK, HD, AE, ZKK, KJ and XNZ. Full text review, data extraction and synthesis was completed by SK, GL, EL, HK, HD, AE, ZKK, KJ and XNZ. The first draft of the manuscript and tables was produced by SK, JB, GL and MD-W, and all authors contributed to subsequent revisions. All authors approved the final version of the article and agreed on its submission for publication. SK is the guarantor.
Funding This work was funded by the Health Foundation’s grant to the University of Cambridge for The Healthcare Improvement Studies (THIS) Institute (RG88620). THIS Institute is supported by the Health Foundation - an independent charity committed to bringing about better health and health care for people in the UK. MD-W was an NIHR Senior Investigator (NF-SI-0617-10026) during the course of this study. The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care, or of the Health Foundation. The funder played no part in the conduct of this review.
Competing interests MD-W, JB, SK, GL, EL and IK report funding from The Health Foundation to THIS Institute. TJD is the obstetrical lead for NHS Resolution. TJD and CW were members of an RCOG/RCM national fetal monitoring group. HK, HD, AE, ZKK, KJ and XNZ report no competing interests.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
1 National Institute for Health and Care Excellence. Fetal monitoring in labour. NICE guideline 229 (NG229). London. 2022. Available: https://www.nice.org.uk/guidance/ng229
2 NICE. Intrapartum care. NICE Guideline 235 (NG235). London: National Institute for Health and Care Excellence, 2023. Available: http://www.nice.org.uk/guidance/ng235
3 Ayres-de-Campos D, Spong CY, Chandraharan E, et al. FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography. Int J Gynaecol Obstet 2015; 131: 13–24. doi:10.1016/j.ijgo.2015.06.020
4 Ekengård F, Cardell M, Herbst A. Impaired validity of the new FIGO and Swedish CTG classification templates to identify fetal acidosis in the first stage of labor. J Matern Fetal Neonatal Med 2022; 35: 4853–60. doi:10.1080/14767058.2020.1869931
5 Houfflin-Debarge V, Closset E, Deruelle P. Surveillance du travail dans les situations à risque. J Gynecol Obstet Biol Reprod 2008; 37: S81–92. doi:10.1016/j.jgyn.2007.11.014
6 ACOG Practice Bulletin No. 106: Intrapartum Fetal Heart Rate Monitoring: Nomenclature, Interpretation, and General Management Principles. Obstet Gynecol 2009; 114: 192–202. doi:10.1097/AOG.0b013e3181aef106
7 Magro M. Five years of cerebral palsy claims - a thematic review of NHS resolution data. London, UK: NHS Resolution, 2017.
8 Andreasen S, Backe B, Øian P. Claims for compensation after alleged birth asphyxia: a nationwide study covering 15 years. Acta Obstet Gynecol Scand 2014; 93: 152–8. doi:10.1111/aogs.12276
9 Hove LD, Bock J, Christoffersen JK, et al. Analysis of 127 peripartum hypoxic brain injuries from closed claims registered by the Danish Patient Insurance Association. Acta Obstet Gynecol Scand 2008; 87: 72–5. doi:10.1080/00016340701797567
10 Berglund S, Grunewald C, Pettersson H, et al. Severe asphyxia due to delivery‐related malpractice in Sweden 1990–2005. BJOG 2008; 115: 316–23. doi:10.1111/j.1471-0528.2007.01602.x
11 NHS Litigation Authority. Ten Years of Maternity Claims - An Analysis of NHS Litigation Authority Data. London, 2012. Available: https://resolution.nhs.uk/wp-content/uploads/2018/11/Ten-years-of-Maternity-Claims-Final-Report-final-2.pdf
12 NHS Resolution. The early notification scheme progress report: collaboration and improved experience for families. An overview of the scheme to date together with thematic analysis of a cohort of cases from year 1 of the scheme 2017–2018. NHS Resolution, 2019.
13 NHS Resolution. The second report: the evolution of the early notification scheme. NHS Resolution, 2022.
14 Ockenden D. Findings, conclusions and essential actions from the independent review of maternity services at the shrewsbury and telford hospital NHS trust. HH Associates Ltd. on behalf of the Controller of Her Majesty’s Stationery Office, 2022.
15 Kirkup B. The Report of the Morecambe Bay Investigation, 2015. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/408480/47487_MBI_Accessible_v0.1.pdf
16 Kirkup B. Reading the signals. Maternity and neonatal services in East Kent–the Report of the Independent Investigation, 2022. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1111992/reading-the-signals-maternity-and-neonatal-services-in-east-kent_the-report-of-the-independent-investigation_print-ready.pdf
17 Draper E, Kenyon S, on behalf of MBRRACE-UK. MBRRACE-UK. Perinatal confidential Enquiry. Term, singleton, intrapartum stillbirth and intrapartum-related neonatal death: The infant mortality and morbidity studies, Department of Health Sciences. University of Leicester: Leicester, 2017.
18 Ennis M, Vincent CA. Obstetric accidents: a review of 64 cases. BMJ 1990; 300: 1365–7. doi:10.1136/bmj.300.6736.1365
19 Ashcroft B. Failures in Childbirth Care. J Health Serv Res Policy 2010; 15: 52–5. doi:10.1258/jhsrp.2009.09s106
20 Miller JH, Page SE. Complex adaptive systems: an introduction to computational models of social life. Princeton, NJ: Princeton University Press, 2007.
21 Devane D, Lalor J. Midwives’ visual interpretation of intrapartum cardiotocographs: intra- and inter-observer agreement. J Adv Nurs 2005; 52: 133–41. doi:10.1111/j.1365-2648.2005.03575.x
22 Rhöse S, Heinis AMF, Vandenbussche F, et al. Inter‐ and intra‐observer agreement of non‐reassuring cardiotocography analysis and subsequent clinical management. Acta Obstet Gynecol Scand 2014; 93: 596–602. doi:10.1111/aogs.12371
23 Kelly S, Redmond P, King S, et al. Training in the use of intrapartum electronic fetal monitoring with cardiotocography: systematic review and meta‐analysis. BJOG 2021; 128: 1408–19. doi:10.1111/1471-0528.16619
24 Safer Childbirth: Minimum Standards for the Organisation and Delivery of Care in Labour. Royal colleges of midwives, obstetricians and gynaecologists, anaesthetists and paediatrics and child health. London, 2007.
25 Brocklehurst P, Field D, Greene K, et al. Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial. The Lancet 2017; 389: 1719–29. doi:10.1016/S0140-6736(17)30568-8
26 NHS. Human factors in healthcare: A concordat from the National Quality Board, 2013. Available: https://www.england.nhs.uk/wp-content/uploads/2013/11/nqb-hum-fact-concord.pdf
27 Vincent C, Moorthy K, Sarker SK, et al. Systems approaches to surgical quality and safety: from concept to measurement. Ann Surg 2004; 239: 475–82. doi:10.1097/01.sla.0000118753.22830.41
28 Reason J. Human error: models and management. BMJ 2000; 320: 768–70. doi:10.1136/bmj.320.7237.768
29 Read GJM, Shorrock S, Walker GH, et al. State of science: evolving perspectives on “human error”. Ergonomics 2021; 64: 1091–114. doi:10.1080/00140139.2021.1953615
30 Lawton R, McEachan RRC, Giles SJ, et al. Development of an evidence-based framework of factors contributing to patient safety incidents in hospital settings: a systematic review. BMJ Qual Saf 2012; 21: 369–80. doi:10.1136/bmjqs-2011-000443
31 Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med 2018; 169: 467–73. doi:10.7326/M18-0850
32 Peters MDJ, Godfrey CM, Khalil H, et al. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc 2015; 13: 141–6. doi:10.1097/XEB.0000000000000050
33 Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci 2010; 5: 69. doi:10.1186/1748-5908-5-69
34 Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005; 8: 19–32. doi:10.1080/1364557032000119616
35 Sager M, Pistone I. Mismatches in the production of a scoping review: Highlighting the interplay of (in)formalities. J Eval Clin Pract 2019; 25: 930–7. doi:10.1111/jep.13251
36 The use of Electronic Fetal Monitoring. The use and interpretation of cardiotocography in intrapartum fetal surveillance. Evidence-based Clinical Guideline Number 8.: RCOG (Royal College of Obstetricians and Gynaecologists). Clinical Effectiveness Support Unit. 2001.
37 American College of Obstetricians and Gynecologists. Practice Bulletin #70: Intrapartum Fetal Heart Rate Monitoring. Obstet Gynecol 2005; 106: 1453–60. doi:10.1097/00006250-200512000-00053
38 World Bank List of Economies, 2019. Available: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
39 Carroll C, Booth A, Cooper K. A worked example of “best fit” framework synthesis: a systematic review of views concerning the taking of some potential chemopreventive agents. BMC Med Res Methodol 2011; 11: 29. doi:10.1186/1471-2288-11-29
40 Carroll C, Booth A, Leaviss J, et al. “Best fit” framework synthesis: refining the method. BMC Med Res Methodol 2013; 13: 37. doi:10.1186/1471-2288-13-37
41 Komashie A, Ward J, Bashford T, et al. Systems approach to health service design, delivery and improvement: a systematic review and meta-analysis. BMJ Open 2021; 11: e037667. doi:10.1136/bmjopen-2020-037667
42 Bewley S, Braillon A. Electronic fetal heart rate monitoring: we need new research approaches. BMJ 2018; 360: k658. doi:10.1136/bmj.k658
43 Andreasen S, Backe B, Jørstad RG, et al. A nationwide descriptive study of obstetric claims for compensation in Norway. Acta Obstet Gynecol Scand 2012; 91: 1191–5. doi:10.1111/j.1600-0412.2012.01409.x
44 Cook R, Rasmussen J. “Going solid”: a model of system dynamics and consequences for patient safety. Qual Saf Health Care 2005; 14: 130–4. doi:10.1136/qshc.2003.009530
45 Hollnagel E. The ETTO Principle: Efficiency-Thoroughness Trade-Off. Why Things That Go Right Sometimes Go Wrong: Ashgate. 2009.
46 Rasmussen J. Risk management in a dynamic society: a modelling problem. Saf Sci 1997; 27: 183–213. doi:10.1016/S0925-7535(97)00052-0
47 Lamé G, Liberati EG, Canham A, et al. Why is safety in intrapartum electronic fetal monitoring so hard? A qualitative study combining human factors/ergonomics and social science analysis. BMJ Qual Saf 2024; 33: 246–56. doi:10.1136/bmjqs-2023-016144
48 Young P, Maclennan K. Human factors in obstetrics. Anaesth & Intensive Care Med 2022; 23: 467–71. doi:10.1016/j.mpaic.2022.05.002
49 Carayon P, Schoofs Hundt A, Karsh B-T, et al. Work system design for patient safety: the SEIPS model. Qual Saf Health Care 2006; 15: i50–8. doi:10.1136/qshc.2005.015842
50 NHS England. Saving Babies’ Lives Version Two. A care bundle for reducing perinatal mortality, 2019. Available: https://www.england.nhs.uk/publication/saving-babies-lives-version-two-a-care-bundle-for-reducing-perinatal-mortality
51 NICE. Intrapartum care for healthy women and babies. London: National Institute for Health and Care Excellence, 2014. Available: https://www.nice.org.uk/guidance/cg190
52 Knight M, Bevan C. Achieving safer maternity care in the UK. BMJ 2021; 372: 45. doi:10.1136/bmj.n45
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Objectives
Suboptimal intrapartum electronic fetal heart rate monitoring using cardiotocography has remained a persistent problem (EFM-CTG). We aimed to identify the range of influences on the safety of using EFM-CTG in practice.
Design
Scoping review to identify influences related to the practice of intrapartum EFM.
Data sources
MEDLINE, Embase, CINAHL, Web of Science, Scopus, British Nursing Index, Cochrane Library, from 1 January 2001 to 25 August 2024, and grey literature.
Eligibility criteria
Articles that reported potential influences on the clinical practice of intrapartum EFM-CTG in hospital-based intrapartum maternity care settings, including primary studies, secondary analyses, reviews, reports, conference abstracts and investigations relevant to maternity and obstetrics, in English. Evaluations of technological modifications to traditional EFM-CTG monitoring and analysis were excluded.
Data extraction and synthesis
We extracted influences on EFM-CTG from the included studies. Findings were synthesised using a best-fit framework approach, structured using an existing 19-domain framework of contributory factors for patient safety incidents in hospitals.
Results
142 articles and 14 reports were included. Our synthesis identified influences on EFM practice across all 19 domains of the contributory factors framework, including those relating to cognitive, social and organisational factors and interactions between professional work and tools used for fetal monitoring.
Conclusion
Reducing avoidable harm associated with electronic fetal monitoring requires a systems approach based on a sound understanding of the full range of influences on practice.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Department of Public Health and Primary Care, THIS Institute (The Healthcare Improvement Studies Institute), University of Cambridge, Strangeways Research Laboratory, Cambridge, UK
2 Department of Public Health and Primary Care, THIS Institute (The Healthcare Improvement Studies Institute), University of Cambridge, Strangeways Research Laboratory, Cambridge, UK; Laboratoire Genie Industriel, CentraleSupélec, Gif-sur-Yvette, France
3 University of Cambridge, Cambridge, Cambridgeshire, UK
4 Medical Library, University of Cambridge, Cambridge, UK
5 Translational Health Sciences, University of Bristol, Bristol, UK
6 Southmead Hospital, PROMPT Maternity Foundation, Bristol, UK
7 THIS Labs, Trumpington Mews, Cambridge, UK